Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 9 Recruiting 4 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 20 Cisplatin 14 Carboplatin 13 Paclitaxel 12 Radiation 11 Doxorubicin 10 Radiotherapy 9 Nivolumab 9 Cyclophosphamide 9 Cytarabine 8 Vincristine 7 Radiotherapy, Intensity-Modulated 7 Metformin 7 Magnetic Resonance Spectroscopy 7 Etoposide 7 Leucovorin 6 Ipilimumab 6 Injections 6 Fluorouracil 6 Docetaxel 6 tislelizumab 5 Specimen Handling 5 Radiotherapy, Conformal 5 Prednisone 5 Pemetrexed 5 Methotrexate 5 Cetuximab 5 Bevacizumab 5 fludarabine 4 durvalumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × trametinib × 30 days × Clear all

NCT02645149 2026-05-29

Match Mel

Melanoma Institute Australia

Phase 2 Completed

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡